Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Axcella Health Inc (AXLA)

Axcella Health Inc (AXLA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 170,256
  • Shares Outstanding, K 34,188
  • Annual Sales, $ 0 K
  • Annual Income, $ -59,040 K
  • 60-Month Beta 1.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.52
  • Number of Estimates 3
  • High Estimate -0.41
  • Low Estimate -0.73
  • Prior Year -0.95
  • Growth Rate Est. (year over year) +45.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.10 +27.32%
on 07/15/20
5.43 -3.86%
on 07/06/20
-0.07 (-1.32%)
since 07/02/20
3-Month
3.90 +33.85%
on 05/18/20
7.73 -32.47%
on 05/11/20
+0.44 (+9.21%)
since 05/04/20
52-Week
2.25 +132.00%
on 03/19/20
8.81 -40.75%
on 08/13/19
-2.20 (-29.65%)
since 08/02/19

Most Recent Stories

More News
Axcella (AXLA) to Report Q2 Earnings: What's in the Cards?

Axcella AXLA) will provide updates on its clinical programs when it releases second-quarter 2020 results.

ALKS : 18.70 (+0.11%)
ACAD : 43.52 (+0.58%)
BLUE : 62.44 (-0.54%)
AXLA : 5.22 (+4.82%)
Flagship Pioneering Expands Executive Team with Appointment of Guillaume Pfefer as CEO-Partner

, /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has further strengthened its executive leadership team with the appointment of life sciences...

AXLA : 5.22 (+4.82%)
DNLI : 23.39 (-3.59%)
EVLO : 3.85 (+0.52%)
KLDO : 6.61 (+5.59%)
MRNA : 78.46 (+0.62%)
RUBY : 5.10 (+1.80%)
MCRB : 4.20 (+2.69%)
SYRS : 10.85 (+4.63%)
Is Axcella Health (AXLA) Outperforming Other Medical Stocks This Year?

Is (AXLA) Outperforming Other Medical Stocks This Year?

AXLA : 5.22 (+4.82%)
Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing

, /PRNewswire/ -- Flagship Pioneering today announced the unveiling of Tessera Therapeutics, Inc. a new company with the mission of curing disease by writing in the code of life. Tessera is pioneering...

AXLA : 5.22 (+4.82%)
Here's Why Hold Strategy is Apt for Select Medical Stock

Select Medical (SEM) is well poised to benefit from improved revenues and strong cash flows.

BKD : 2.79 (+0.36%)
SEM : 19.30 (+1.74%)
ABEO : 2.92 (-1.02%)
AXLA : 5.22 (+4.82%)
XOMA (XOMA) Catches Eye: Stock Jumps 5.2%

XOMA (XOMA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

XOMA : 16.94 (-1.74%)
AXLA : 5.22 (+4.82%)
Axcella Health Inc. (AXLA) Moves to Strong Buy: Rationale Behind the Upgrade

Axcella Health Inc. (AXLA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AXLA : 5.22 (+4.82%)
Has Axcella Health (AXLA) Outpaced Other Medical Stocks This Year?

Is (AXLA) Outperforming Other Medical Stocks This Year?

AXLA : 5.22 (+4.82%)
Exelixis (EXEL) in Focus: Stock Moves 7.6% Higher

Exelixis (EXEL) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

EXEL : 23.45 (-1.01%)
AXLA : 5.22 (+4.82%)
Ultragenyx Gets FDA Nod for Label Expansion of Crysvita

Ultragenyx (RARE) gets FDA approval for the label expansion of Crysvita into tumor-induced osteomalacia.

BAYRY : 16.8200 (-3.22%)
RARE : 84.17 (+0.75%)
AKCA : 11.19 (+2.47%)
AXLA : 5.22 (+4.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AXLA with:

Business Summary

Axcella Health Inc. is a biotechnology company. It is engaged in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. The company's principal candidate consists of AXA1665, AXA1125, AXA1957, AXA2678 and AXA4010 which are in clinical...

See More

Key Turning Points

2nd Resistance Point 5.48
1st Resistance Point 5.35
Last Price 5.22
1st Support Level 5.02
2nd Support Level 4.82

See More

52-Week High 8.81
Fibonacci 61.8% 6.30
Fibonacci 50% 5.53
Last Price 5.22
Fibonacci 38.2% 4.76
52-Week Low 2.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar